India is launching ambitious science initiatives. However, current financial rules designed for conventional procurement hinder R&D. A new ...

Union Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...

With India’s leadership and BRICS+ cooperation, agriculture can become not only a source of food, but a foundation for resilience, prosperi...

India is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...

Today, India is the world’s largest producer of milk, pulses, and spices; the largest exporter of rice; and among the leading producers of ...

India and Oman's Comprehensive Economic Partnership Agreement, CEPA, begins on June 1. This pact offers Indian exports 100% duty-free acces...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...

Indian pharmaceutical exports reached over $31 billion in FY26. March saw a significant 23% drop, primarily due to a slowdown in the United...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Whether you are a trader or an investor, there is one thing to watch carefully in the coming days: Earnings. The reason why this is importa...

India's pharma exports saw a sharp 23.17% fall in March. The West Asia war disrupted shipping routes and air transit hubs. This led to incr...

Indian pharmaceutical exports are performing strongly. Shipments neared $29 billion by February this financial year. This growth continues ...